“…The anti-inflammatory action of BAs has been attributed due to the inhibition of 5-lipoxygenase in a selective, nonredox, and non-compititive way (Ammon et al, 1991) as compared to other inhibitors of the enzyme 5-lopoxygenase which posess disadvantages because of their non-selectivity, in this manner BAs have advantages of less danger and constrained symptoms when contrasted with other antiinflammatory medications (Ammon et al, 1993;Safayhi et al, 1995;Siemoneit et al, 2009). Earlier studies have suggested that both KBA and AKBA interfere with production of leukotrienes by inhibition 5-lipoxygenase; however, more recent research has shown that other BAs specially b-boswellic acid also play an important role, targeting the microsomal prostaglandin (PG) E2 synthase-1 (mPGES-1) as well as cathepsin G (CatG) thereby complementing the inflammatory action of KBA and AKBA (Tausch et al, 2009;Abdel et al, 2011;Siemoneit et al, 2011;Skarke et al, 2012).…”